284 related articles for article (PubMed ID: 15681520)
21. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
22. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
[TBL] [Abstract][Full Text] [Related]
23. Frozen hope: fertility preservation for women with cancer.
Quinn GP; Vadaparampil ST; Jacobsen PB; Knapp C; Keefe DL; Bell GE;
J Midwifery Womens Health; 2010; 55(2):175-80. PubMed ID: 20189137
[TBL] [Abstract][Full Text] [Related]
24. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century.
Ganz PA
Am J Med; 2005 Dec; 118 Suppl 12B():136-41. PubMed ID: 16414339
[TBL] [Abstract][Full Text] [Related]
26. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.
Schover LR
J Clin Oncol; 2008 Feb; 26(5):753-8. PubMed ID: 18258983
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-related amenorrhea in premenopausal women with breast cancer.
Lee S; Kil WJ; Chun M; Jung YS; Kang SY; Kang SH; Oh YT
Menopause; 2009; 16(1):98-103. PubMed ID: 18849877
[TBL] [Abstract][Full Text] [Related]
28. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
[TBL] [Abstract][Full Text] [Related]
29. Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.
Shapiro CL; Phillips G; Van Poznak CH; Jackson R; Leboff MS; Woodard S; Lemeshow S
Breast Cancer Res Treat; 2005 Mar; 90(1):41-6. PubMed ID: 15770525
[TBL] [Abstract][Full Text] [Related]
30. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
Richardson LC; Wang W; Hartzema AG; Wagner S
Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
[TBL] [Abstract][Full Text] [Related]
31. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
Hassett MJ; O'Malley AJ; Pakes JR; Newhouse JP; Earle CC
J Natl Cancer Inst; 2006 Aug; 98(16):1108-17. PubMed ID: 16912263
[TBL] [Abstract][Full Text] [Related]
32. Natural menopause and ovarian toxicity associated with breast cancer therapy.
Knobf MT
Oncol Nurs Forum; 1998 Oct; 25(9):1519-30; quiz 1531-2. PubMed ID: 9802049
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
34. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
[TBL] [Abstract][Full Text] [Related]
35. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
[TBL] [Abstract][Full Text] [Related]
36. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
[TBL] [Abstract][Full Text] [Related]
37. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
[TBL] [Abstract][Full Text] [Related]
38. Reproductive health assessment for women with cancer: a pilot study.
Patel A; Sreedevi M; Malapati R; Sutaria R; Schoenhage MB; Patel AR; Radeke EK; Zaren HA
Am J Obstet Gynecol; 2009 Aug; 201(2):191.e1-4. PubMed ID: 19539896
[TBL] [Abstract][Full Text] [Related]
39. Ovarian function and childbearing issues in breast cancer survivors.
Gadducci A; Cosio S; Genazzani AR
Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
[TBL] [Abstract][Full Text] [Related]
40. Psychosocial problems among younger women with breast cancer.
Avis NE; Crawford S; Manuel J
Psychooncology; 2004 May; 13(5):295-308. PubMed ID: 15133771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
